Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.

Micha SimonRojda IpekGyörgy A HomolaDamiano M RovitusoAndrea SchampelChristoph KleinschnitzStefanie Kuerten

Published in: Journal of neuroinflammation (2018)

Anti-CD52 treatment abrogated B cell infiltration and disrupted existing B cell aggregates in the CNS.

Keyphrases